http://www.asm.org/modules/mod_image_show_gk4/cache/mSphere Direct herogk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Podcast Hero Banner3gk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Microbe Online Program Plannergk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/AAAS Fellows Bannergk-is-651.jpglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Read New JMBE Bannergk-is-651.jpglink
0 1 2 3 4
Progress bar
21-01-2017mSphere Direct
21-01-2017Podcast banner
21-01-2017AAAS Fellows
21-01-2017Read new JMBE
Become a member today!
JOIN/RENEW
Submit to an ASM Journal
SUBMIT
Attend ASM Biothreats Meeting
REGISTER

bonomo robertDr. Bonomo's laboratory studies the genetic and biochemical basis of beta-lactam resistance mediated by beta-lactamases and penicillin binding proteins in Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. To these ends he is interested in beta-lactam antibiotics and beta-lactamase inhibitors as novel therapeutics. He has also explored structure-function relationships of SHV and KPC beta-lactamases with BLIP, the beta-Lactamase Inhibitory Protein. Recent work is focused on novel approaches to understanding the molecular epidemiology and rapidly detecting multidrug-resistant (MDR) Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae. In addition, he is interested in the complex genetic background and genome sequence of MDR A. baumannii, extended-spectrum beta-lactamase and carbapenem resistant K. pneumoniae. Dr. Bonomo's lab also seeks to apply molecular diagnostics to define the transmissibility and resistance profile of S. aureus.

TPL_asm2013_SEARCH

91087